Malaria Vaccine Saves 1 in 8 Children Across Africa

A vaccine that once seemed impossible is now saving thousands of children's lives across Africa, where malaria kills more people than anywhere else on Earth.

The RTS,S malaria vaccine has been quietly working its way through childhood vaccination programs in 25 African countries since the World Health Organization first recommended it in 2021. Now, five years in, researchers have the numbers to prove it's making a real difference.

A study tracking 158 communities across Ghana, Kenya, and Malawi found something remarkable. In areas where children received the vaccine, roughly one in eight deaths were prevented over a 46-month period.

That might sound like a small fraction, but it adds up fast. Malaria kills about 579,000 people across Africa each year, with three-quarters of those deaths being children under five. Preventing even one in eight of those deaths means tens of thousands of families who don't have to bury their babies.

The vaccine targets Plasmodium falciparum, the deadliest type of malaria parasite. Combined with other prevention tools like bed nets and treatments, these efforts prevented more than 170 million malaria cases and around 1 million deaths worldwide in 2024.

Four African countries have now been certified malaria-free by WHO: Algeria, Mauritius, Cabo Verde, and Egypt. They're proof that beating this ancient disease is possible.

The momentum keeps building. In April, WHO approved the first anti-malaria treatment designed specifically for newborns and young infants. That matters enormously, since about 30 million babies are born each year in parts of Africa where malaria is common.

The Bright Side

The vaccine's success shows what happens when global health efforts stick with a problem long enough to solve it. Scientists worked for decades to develop a malaria vaccine that actually worked, facing failure after failure. The RTS,S vaccine isn't perfect, but it doesn't have to be. It just has to save lives, and that's exactly what it's doing.

More than 10 million African children now get these shots as part of their routine vaccinations, right alongside measles and polio vaccines. Parents don't have to seek out special clinics or pay extra fees. The protection comes as part of regular childhood care.

There are still challenges ahead. A new mosquito species called Anopheles stephensi, originally from South Asia, has started spreading through African cities. Unlike rural mosquitoes, this species thrives in urban water containers and survives scorching dry seasons when malaria usually slows down.

Scientists estimate this urban-adapted mosquito could expose another 120 million Africans to malaria as cities continue growing. But the vaccine that's already saving children can help protect them too.

After decades of watching malaria steal young lives, Africa finally has a weapon that's turning the tide.